{"error":"Wordpress Error : Order amount less than minimum amount allowed"} Our Blogs - Kalpaka Charitable Trust | NGO Charity
Kalpaka Charitable Trust

News

Corporate Social Responsibility Earth - Kalpaka

What is mean by CSR: A Commitment to Positive Impact

CSR mean (Corporate Social Responsibility) is a concept in which companies voluntarily contribute to a better society and a cleaner environment. The companies integrate social and other valuable concerns in their business operations to better their stakeholders and community in general voluntarily. It was introduced under Section 135 of the Companies Act 2013 of the Indian Constitution.

Read More

help the victims of the COVID - Kalpaka

Understanding the Possibility of a Third Wave in India

What is a wave?

A ‘wave’ in terms of a disease means the rising and falling trends of a disease’s impact over a long period.

The first wave of COVID-19 in India reached a peak in September 2020, and the second wave started in March-April 2021.

Read More

health guide for the Pandemic

Pandemic Safety Guidelines: Protecting Your Health and Community

The COVID-19 Pandemic has changed our lives drastically, and none of us can indeed say that we are protected from getting infected. The usual guidelines of maintaining a healthy lifestyle – eating healthy food, regular but non-exhaustive exercise, managing stress, and adequate sleep are not scientifically proven to boost immunity. Instead, we need overall supportive nutrition strategies, proper hygiene measures, social distancing, and quarantine rules.

Read More

Mucormycosis linked with COVID

Mucormycosis Treatment: Effective Approaches and Options

Mucormycosis (black mold) is a rare but dangerous fungal infection from molds called mucormycetes in the air, which affects the nose and the sinus. It can get through a cut on the skin too. People vulnerable to mucormycosis are the ones with health problems and take medicines that lower their immunity. The more highlighted categories of victims are people with high blood sugar (Hyperglycemia) and patients recovering from COVID. Some people had started taking COVID prescribed medicines to build immunity against the virus even if they got a common cold, and that was enough pretext to lower their immunity.

Absolutely, discussing mucormycosis in relation to COVID-19 involves understanding the risks, symptoms, treatments, and preventive measures associated with this fungal infection in the context of the pandemic. Here’s an extensive piece on this topic:


Understanding Mucormycosis and its Correlation with COVID-19

The COVID-19 pandemic has not only brought about the challenges of combating a viral infection but has also unveiled a series of secondary health concerns. Among these is the emergence of mucormycosis, a rare but potentially fatal fungal infection, particularly prevalent among COVID-19 patients. This article delves into the intricacies of mucormycosis, its connection with COVID-19, its risk factors, symptoms, treatments, and preventive measures.

The COVID-19 pandemic has brought various challenges, one of which is the emergence of secondary infections, particularly mucormycosis, among individuals battling the virus. Mucormycosis, often termed black fungus, is a rare but severe fungal infection caused by a group of molds known as mucormycetes. Understanding the relationship between mucormycosis and COVID-19 is essential in comprehending the risks, symptoms, preventive measures, and treatment options associated with these conditions.

Mucormycosis is a fungal infection caused by the inhalation of fungal spores present in the environment. These spores commonly reside in soil, organic matter, and decaying vegetation. While it’s a relatively rare infection, it can be extremely serious, especially in individuals with weakened immune systems or underlying health conditions.

Risk Factors for Mucormycosis in COVID-19 Patients

Several factors contribute to the increased risk of mucormycosis among COVID-19 patients:

  1. Steroid Usage: Prolonged and/or excessive use of steroids to manage severe COVID-19 cases weakens the immune system, paving the way for fungal infections.
  2. Diabetes: Uncontrolled blood sugar levels, commonly observed in COVID-19 patients with diabetes, create an environment conducive to fungal growth.
  3. Immunocompromised State: Individuals with compromised immune systems due to pre-existing conditions or medical treatments are more susceptible.

Symptoms of Mucormycosis

Mucormycosis can manifest in various forms depending on the site of infection. Common types include rhino-orbital-cerebral mucormycosis (affecting the sinuses, eyes, and brain), pulmonary mucormycosis (involving the lungs), cutaneous mucormycosis (affecting the skin), and gastrointestinal mucormycosis (involving the digestive tract).

Mucormycosis in the Context of COVID-19

The link between mucormycosis and COVID-19 has gained attention, particularly in countries experiencing surges in COVID-19 cases. Several factors contribute to this connection:

Weakened Immune System: COVID-19 can compromise the immune system, making individuals more susceptible to secondary infections, including mucormycosis. Prolonged hospitalization, steroid treatments, and comorbidities further weaken the body’s defense mechanisms, increasing the risk of opportunistic infections like mucormycosis.

Steroid Usage: Corticosteroids have been a vital part of COVID-19 treatment, especially in managing severe cases and reducing inflammation in the lungs. However, prolonged and indiscriminate use of steroids can suppress the immune system, creating a conducive environment for fungal infections to thrive.

Oxygen Therapy: The use of oxygen therapy, particularly through ventilators or respirators, is crucial in treating severe COVID-19 cases. However, the moist environment created by these devices can potentially facilitate the growth of fungi when proper hygiene measures are not maintained.

The Connection Between Mucormycosis and COVID-19

The association between mucormycosis and COVID-19 gained attention due to an increase in reported cases, especially among COVID-19 patients with comorbidities or those who have been treated with steroids. Steroids, a common treatment for severe COVID-19 cases, can suppress the immune system, making individuals more susceptible to opportunistic infections like mucormycosis.

Preventive Measures

Preventing mucormycosis in COVID-19 patients involves a multifaceted approach:

  1. Rational Use of Steroids: Healthcare professionals should judiciously prescribe steroids, considering the risk-benefit ratio, duration, and dosage.
  2. Monitoring Blood Sugar Levels: Strict monitoring and control of blood sugar levels in diabetic COVID-19 patients can help reduce the risk.
  3. Maintaining Hygiene: Strict adherence to hygiene protocols, including sterile water for humidification during oxygen therapy and maintaining clean environments in healthcare settings, is crucial.
  4. Timely Intervention: Early detection of symptoms and immediate medical attention can significantly improve outcomes.

General Symptoms May Include:

  • Facial pain
  • Nasal congestion or bleeding
  • Black lesions on the nasal bridge or inside the mouth
  • Headaches
  • Fever
  • Shortness of breath
  • Coughing up blood (in pulmonary cases)
  • Skin lesions

Symptoms and Diagnosis

Identifying mucormycosis in COVID-19 patients requires vigilance. The symptoms may vary depending on the type and site of infection, but they often include:

  • Facial pain or numbness (in rhinocerebral mucormycosis)
  • Nasal congestion or discharge
  • Black lesions on nasal bridge or palate
  • Cough, chest pain, and difficulty breathing (in pulmonary mucormycosis)
  • Gastrointestinal issues like abdominal pain, nausea, and vomiting (in gastrointestinal mucormycosis)
  • Skin lesions or ulcers (in cutaneous mucormycosis)

Prompt diagnosis is critical. Imaging studies, such as CT scans or MRIs, along with biopsies, are essential for confirming mucormycosis. Early detection significantly improves treatment outcomes.

Read More

Rural India need Urban India’s help

Exploring the Dynamics of Urban Community and Rural Community

What is an ‘urban’ and a ‘rural’ area?

Though the rural community is somehow the backbone of the urban economy, the urban community is better positioned to help the rural community in distress. This is because urban areas are densely populated areas with artificial surroundings and the population engaged in trade, commerce, or services. On the other hand, rural areas mean villages or hamlets outside the city’s boundaries with a low population density and large areas of undeveloped land forming the main occupation of its inhabitants-agriculture and animal husbandry. In India, a town with a population below 15000 is considered a rural area.

Read More

Want to help, but don’t know where to start? Volunteer with us.